Diphenhydramine Hcl Capsule
FDA Label NDC 66267-779

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Nucare Pharmaceuticals, Inc. for the product Diphenhydramine Hcl (NDC 66267-779). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient(in each capsule), purpose, uses:, warnings:, do not use, ask a doctor or pharmacist before use, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient(In Each Capsule)

Diphenhydramine HCL 50 mg

Uses:

  • Temporarily relieves these symptoms associated with the common cold, hay fever, or other respiratory allergies.
  • Sneezing.
  • Nasal congestion.
  • Runny nose.
  • Itchy, watery eyes.

Warnings:


Do Not Use

  • With any other product containing Diphenhydramine HCL, including one applied topically.

When Using This Product

  • Avoid alcoholic drinks.
  • Marked drowsiness may occur.
  • Excitability may occur, especially in children.
  • Alcohol, sedatives and tranquilizers may increase drowsiness.
  • Be careful when driving a motor vehicle or operating machinery.

Other Information:

  • Store at room temperature 15-30  degrees C (59-86 degrees F)
  • Protect from excessive moisture

Questions? Adverse Drug Event Call:

1-800-687-0176

* Please review the disclaimer below.